Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up
Authors
Keywords
Ki67 cut-offs, Prognostic index, Luminal breast cancer, Relapse
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 157, Issue 2, Pages 363-371
Publisher
Springer Nature
Online
2016-05-07
DOI
10.1007/s10549-016-3817-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- An international study to increase concordance in Ki67 scoring
- (2015) Mei-Yin C Polley et al. MODERN PATHOLOGY
- Reply to Ki67 in breast cancer: a useful prognostic marker!
- (2014) C. Denkert et al. ANNALS OF ONCOLOGY
- Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values
- (2014) Gábor Cserni et al. BREAST
- Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial
- (2013) C. Denkert et al. ANNALS OF ONCOLOGY
- Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
- (2013) A. Schneeweiss et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study
- (2013) Yoshiki Mikami et al. CANCER SCIENCE
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer
- (2012) Einar Gudlaugsson et al. HISTOPATHOLOGY
- How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
- (2012) Zsuzsanna Varga et al. PLoS One
- Is the Ki-67 labelling index ready for clinical use?
- (2011) W. Jonat et al. ANNALS OF ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Improved Staging in Node-Positive Breast Cancer Patients Using Lymph Node Ratio: Results in 1,788 Patients with Long-term Follow-Up
- (2010) Melissa E. Danko et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started